ACM
ONCY

Aquatic Capital Management’s Oncolytics Biotech ONCY Stock Holding History

Aquatic Capital Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-600
Closed -$1K – 1455
2022
Q2 		$1K Sell
600
-700
-54% -$851 ﹤0.01% 1132
2022
Q1 		$2K Sell
1,300
-1,300
-50% -$2.18K ﹤0.01% 976
2021
Q4 		$4K Buy
+2,600
New +$4.81K 0.01% 977

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Aquatic Capital Management's ONCY Position: Q3 2022 in Review

Aquatic Capital Management sold out of Oncolytics Biotech (ONCY) in Q3 2022, closing a stake of 600 shares — an estimated $1K sold.

Aquatic Capital Management first reported a position in ONCY in Q4 2021 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 36 funds tracked by Wall St. Rank hold ONCY as of Q3 2022.

  • Aquatic Capital Management reported no remaining Oncolytics Biotech position as of Q3 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 600 Oncolytics Biotech shares in Q3 2022, an estimated $1K.
  • Aquatic Capital Management first reported a position in Oncolytics Biotech in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's Oncolytics Biotech position peaked at $4K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2022.

Based on Aquatic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.